← Back to Clinical Trials
Recruiting NCT00900471

NCT00900471 Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT00900471
Status Recruiting
Phase
Sponsor Wake Forest University Health Sciences
Condition Unspecified Adult Solid Tumor, Protocol Specific
Study Type OBSERVATIONAL
Enrollment 20,000 participants
Start Date 2004-04-01
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 120 Years
Study Type OBSERVATIONAL
Interventions
biologic sample preservation proceduremedical chart review

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20,000 participants in total. It began in 2004-04-01 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

RATIONALE: Collecting and storing samples of tissue or blood from patients with cancer for study in the laboratory may help the study of cancer in the future PURPOSE: This research study is collecting and storing blood and tissue samples from patients with suspected solid tumors.

Eligibility Criteria

Inclusion Criteria: * Signed protocol specific informed consent prior to registration/randomization. * Clinically suspected solid tumor AND scheduled for surgical resection and/or biopsy

Contact & Investigator

Central Contact
Principal Investigator

Edward A. Levine, MD

STUDY CHAIR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT00900471 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Unspecified Adult Solid Tumor, Protocol Specific. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT00900471 currently recruiting?

Yes, NCT00900471 is actively recruiting participants. Contact the research team at Sarah.Davis@advocatehealth.org for enrollment information.

Where is the NCT00900471 trial being conducted?

This trial is being conducted at Winston-Salem, United States.

Who is sponsoring the NCT00900471 clinical trial?

NCT00900471 is sponsored by Wake Forest University Health Sciences. The principal investigator is Edward A. Levine, MD at Wake Forest University Health Sciences. The trial plans to enroll 20,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology